IMNP Must Read DD: O/S Just 72 Million https://www.otcmarkets.com/stock/IMNP/security Bertilimumab Drug in 4 Phase 2 Trials : https://www.immunepharma.com/what-we-do/bertilimumab Extera Partners to Pursue Bertilimumab Strategic Transaction https://www.otcmarkets.com/stock/IMNP/news/Immune-Pharmaceuticals-Engages-Extera-Partners-to-Pursue-Bertilimumab-Strategic-Transaction?id=213594 Extera Partners Closed Deals with Sanofi, Biogen, Januss, Novellus etc. http://exterapartners.com/